Literature DB >> 17415367

NMR-based prediction of cardiovascular risk in diabetes.

Ronan Roussel, France Mentré, Nadia Bouchemal, Samy Hadjadj, Michel Lièvre, Gilles Chatellier, Joël Menard, Xavière Panhard, Anne Le Hénanff, Michel Marre, Laurence Le Moyec.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17415367      PMCID： PMC2078598          DOI： 10.1038/nm0407-399

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.

Authors:  Joanne T Brindle; Henrik Antti; Elaine Holmes; George Tranter; Jeremy K Nicholson; Hugh W L Bethell; Sarah Clarke; Peter M Schofield; Elaine McKilligin; David E Mosedale; David J Grainger
Journal:  Nat Med       Date:  2002-11-25       Impact factor: 53.440

2.  Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients.

Authors:  Laurence Le Moyec; Paul Valensi; Jean-Christophe Charniot; Edith Hantz; Jean-Paul Albertini
Journal:  NMR Biomed       Date:  2005-11       Impact factor: 4.044

3.  Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.

Authors:  M Wei; S P Gaskill; S M Haffner; M P Stern
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

4.  Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

Authors:  Michel Marre; Michel Lievre; Gilles Chatellier; Johannes F E Mann; Philippe Passa; Joël Ménard
Journal:  BMJ       Date:  2004-02-11

5.  Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

Authors:  Heide L Kirschenlohr; Julian L Griffin; Sarah C Clarke; Ranyl Rhydwen; Andrew A Grace; Peter M Schofield; Kevin M Brindle; James C Metcalfe
Journal:  Nat Med       Date:  2006-05-28       Impact factor: 53.440
  5 in total
  3 in total

Review 1.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 2.  The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.

Authors:  Naomi J Rankin; David Preiss; Paul Welsh; Karl E V Burgess; Scott M Nelson; Debbie A Lawlor; Naveed Sattar
Journal:  Atherosclerosis       Date:  2014-09-30       Impact factor: 5.162

Review 3.  Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application.

Authors:  Matthias S Klein; Jane Shearer
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.